Published: 09, Oct 2026

Ultrasound Aesthetic Devices Market

Ultrasound Aesthetic Devices Market Size, Share and Analysis By Technology (High-Intensity Focused Ultrasound (HIFU), Hybrid Ultrasound Systems, Micro-Focused Ultrasound with Visualization (MFU-V), Ultrasound Cavitation Systems, Others), By Portability (Console Systems, Compact Systems), By Application (Skin Tightening & Lifting, Fat Reduction, Skin Resurfacing, Cellulite Reduction, Others), By End User (Cosmetic Surgery Clinics, Wellness Centers, Hospitals, Consumer Use), and Regional Forecast Till 2034

Download Free Sample

Market Size (2025):

USD 1.24 Billion

CAGR (2026–2034):

10.1%

Report Pages:

165–175

Market Tables:

58–68

Table of Content

Get a free sample of this report

Overview

The global Ultrasound Aesthetic Devices Market was valued at USD 1.24 billion in 2025 and is projected to reach USD 2.95 billion by 2034, growing at a CAGR of 10.1% during the forecast period (2026–2034). The market growth is driven by increasing demand for non-invasive aesthetic treatments, rising adoption of ultrasound-based skin tightening and body contouring procedures, growing consumer preference for minimally invasive cosmetic procedures, expanding use of advanced ultrasound technologies in aesthetic clinics and medical spas. The market is shifting from single-purpose, dot-mode HIFU devices toward multi-modality, linear- and parallel-beam ultrasound platforms that shorten treatment time, reduce patient discomfort, and integrate real-time visualization for more precise energy delivery. The U.S. Food and Drug Administration cleared expanded body-area indications (arms, abdomen and knees) for a leading micro-focused ultrasound platform, while national medical-products regulators in Asia, including China's National Medical Products Administration, approved new market entries for ultrasound-based systems in 2026, broadening commercial access in high-growth Asian markets. By region, Asia-Pacific held the largest share of the market in 2025, supported by a dense manufacturing and innovation base of Korean and Chinese HIFU device makers and high per-capita adoption of non-surgical aesthetic procedures across South Korea, China, and Japan. North America is expected to be the fastest-growing region during the forecast period, driven by an active pipeline of FDA clearances, direct commercial expansion by Asian manufacturers into the U.S. market, and rising consumer demand for non-invasive alternatives to surgical facelifts and body-contouring procedures.

Market Size & Share

CAGR (2026–2034):

Market Snapshot

Study Period:	2021-2034
Market Size in 2025:	USD 1.24 Billion
Market Size in 2026:	USD 1.37 Billion
Market Size by 2034:	USD 2.95 Billion
Unit Value:	USD Billion
Projected CAGR:	10.1% (2026–2034)
Largest Region:	Asia-Pacific
Fastest-Growing Region:	North America
Fastest-Growing Segment (By Application):	Fat Reduction

Market Dynamics

Key Market Trend:

Multi-Modality and Linear-Beam Ultrasound Platforms Emerging as a Transformational Trend

Manufacturers are increasingly combining ultrasound with radiofrequency or micro-needling radiofrequency in a single platform, allowing clinics to address skin tightening and volumetric contouring in one session and reducing the number of devices a practice needs to operate.
Adoption of linear- and parallel-beam ultrasound delivery, which replaces older single-point 'dot mode' energy delivery, is shortening in-clinic treatment times and is being positioned by manufacturers as a lower-discomfort alternative for patients who previously avoided HIFU treatments.
Device makers are shifting commercial models from third-party distribution toward direct clinic relationships and subscription-like consumable-cartridge revenue, a structural change that is improving manufacturer margins and increasing switching costs for clinics.
Classys Inc., a Republic of Korea-listed (KOSDAQ: 214150) manufacturer of the Ultraformer HIFU platform, reported first-quarter 2026 consolidated revenue of KRW 87.2 billion, up 13.1% year-on-year, and issued full-year 2026 revenue guidance of approximately KRW 490 billion, representing about 45% year-on-year growth, reflecting direct operating expansion in Brazil, the United States, and Europe.

Key Market Driver:

Rising Consumer Preference for Non-Invasive Alternatives to Surgical Facelifts is Driving Market Growth

Consumers across developed and emerging markets are increasingly substituting surgical facelifts and body-contouring surgery with non-invasive ultrasound treatments that require no incision and little to no recovery downtime, widening the addressable patient base beyond traditional surgical candidates.
An aging population base in North America, Europe and parts of East Asia is sustaining structural demand for skin-laxity treatments, while rising disposable income and aesthetic awareness among younger demographics in Asia-Pacific is expanding first-time treatment volumes.
Expanding regulatory clearances for new body areas are directly enlarging the addressable procedure base for existing device platforms without requiring new capital equipment purchases by clinics.
Merz Aesthetics announced U.S. FDA clearance of its Ultherapy PRIME micro-focused ultrasound platform for skin laxity on the anterior arms, posterior arms and abdomen, and separately received clearance for knee skin laxity, extending the platform's indications from the face and neck to multiple body areas for the first time.

Key Market Opportunity:

China Market Entry and Platform Consolidation Creating Significant Growth Opportunity

Direct entry into China by leading Korean manufacturers, supported by new National Medical Products Administration approvals, opens access to one of the world's largest medical aesthetics markets, which industry sources estimate at roughly USD 20 billion for non-invasive and minimally invasive procedures.
Private-equity-backed consolidation is creating larger, better-capitalized platforms able to fund international regulatory filings, direct sales forces and clinical evidence generation, opening opportunities for scaled global expansion that smaller independent device makers could not previously fund on their own.
Growing clinic demand for combination and multi-application platforms creates opportunity for manufacturers to expand consumable and applicator portfolios on an existing installed base, generating incremental high-margin revenue without new capital equipment sales.
Sofwave Medical Ltd. announced it had received approval from China's National Medical Products Administration to market the Sofwave System in mainland China, describing the non-invasive/minimally invasive segment of China's medical aesthetics market as valued at approximately RMB 146.0 billion (about USD 20.6 billion) in 2023.

Ultrasound Aesthetic Devices Market Size, 2025–2034 (USD Billion)

Segmentation Analysis

Analysis by Technology

High-Intensity Focused Ultrasound (HIFU) held the largest market share in 2025 because it is the most clinically established and widely installed ultrasound aesthetic modality, with a large body of published clinical evidence, broad regulatory clearance across major markets, and the widest base of trained practitioners. Its ability to target the SMAS layer for facial lifting without surgery has made it the reference technology against which newer ultrasound modalities are benchmarked, sustaining continued replacement and upgrade purchases by established clinics.

Hybrid Ultrasound Systems is projected to grow at the fastest CAGR during the forecast period. Rising clinic demand for platforms that deliver both skin tightening and volumetric body contouring from a single console is driving faster adoption of hybrid ultrasound-radiofrequency and ultrasound-microneedling systems, which reduce the number of devices a clinic must purchase and improve equipment utilization rates.

Technology categories include

· High-Intensity Focused Ultrasound (HIFU) (Dominating Segment)

· Hybrid Ultrasound Systems (Highest CAGR Segment)

· Micro-Focused Ultrasound with Visualization (MFU-V)

· Ultrasound Cavitation Systems

· Others

Analysis by Portability

Console Systems held the largest market share in 2025 because these fixed-installation platforms remain the preferred choice of high-volume dermatology clinics and hospital-based aesthetic departments, which favor their higher energy output, multi-applicator configurations and integrated visualization systems for a broader range of treatment protocols.

Compact Systems is projected to grow at the fastest CAGR during the forecast period. Lower upfront capital requirements and growing demand from independent practitioners, medical spas and mobile aesthetic practices are driving faster uptake of portable systems, particularly in price-sensitive and emerging markets where clinics are expanding treatment menus without large capital budgets. Increasing demand for on-site and multi-location aesthetic services is further supporting adoption of compact ultrasound platforms.

Portability categories include

· Console Systems (Dominating Segment)

· Compact Systems (Highest CAGR Segment)

Analysis by Application

Skin Tightening & Lifting held the largest market share in 2025 because facial and neck skin laxity remains the most common and best-clinically-validated indication for ultrasound aesthetic devices, supported by decades of published outcomes data for HIFU and MFU-V platforms and the largest global base of trained practitioners offering the procedure. Established treatment protocols and growing availability across dermatology clinics, aesthetic centers and medical spas are further strengthening segment adoption.

Fat Reduction is projected to grow at the fastest CAGR during the forecast period. Expanding regulatory clearances for arm, abdomen and other body-area indications, combined with rising consumer interest in non-surgical alternatives to body-contouring surgery, are driving faster growth in ultrasound-based body applications relative to long-established facial indications. Growing awareness of targeted fat-reduction procedures and increasing availability of combination body-contouring treatments are further expanding demand.

Application categories include

· Skin Tightening & Lifting (Dominating Segment)

· Fat Reduction (Highest CAGR Segment)

· Skin Resurfacing

· Cellulite Reduction

· Others

Analysis by End User

Cosmetic Surgery Clinics held the largest market share in 2025 because these clinics represent the primary point of care for energy-based aesthetic treatments, combining physician oversight, the highest-end equipment configurations and the greatest treatment volume per installed device. Established patient bases and continued investment in premium aesthetic technologies are further supporting segment growth.

Wellness Centers is projected to grow at the fastest CAGR during the forecast period. The lower capital and staffing requirements of portable ultrasound systems are enabling faster expansion of treatment menus at medical spas and wellness centers, a channel that is growing its share of total aesthetic-device installations faster than traditional clinics. Flexible treatment offerings and increasing demand for convenient aesthetic services are further supporting adoption across wellness-focused facilities.

End User categories include

· Cosmetic Surgery Clinics (Dominating Segment)

· Wellness Centers (Highest CAGR Segment)

· Hospitals

· Consumer Use

By Region

Ultrasound Aesthetic Devices Market Regional Analysis

Ultrasound Aesthetic Devices Market Share 2025, by Region

Regional Analysis

Asia-Pacific held the largest share of the Ultrasound Aesthetic Devices Market in 2025, driven by South Korea's dense cluster of HIFU device manufacturers, including Classys, Jeisys Medical, Hironic and WONTECH, which collectively supply both the domestic market and export channels across Asia, the Middle East and Latin America. China represents the region's largest growth frontier: Classys has targeted a 2026 China market entry pending regulatory approval, while Sofwave Medical received National Medical Products Administration approval for mainland China in September 2026. Japan is viewed by several manufacturers as a strategic direct-operations hub for further Asian expansion. Government-backed medical-device export promotion in South Korea and continued clinical training investment by regional distributors are reinforcing the region's manufacturing and adoption leadership.

North America is projected to grow at the fastest CAGR during the forecast period, supported by an active U.S. FDA clearance pipeline that is steadily expanding approved treatment areas for established platforms, and by direct commercial entry into the United States by Asian manufacturers such as Classys, which launched its Everesse platform in the U.S. market in late 2024. Merz Aesthetics, headquartered in Germany with its aesthetics business led from the United States, continues to expand Ultherapy PRIME indications in the U.S. market, most recently to the arms, abdomen and knees in November 2025. Strong reimbursement-independent, cash-pay consumer demand for non-surgical facelift alternatives and a well-established base of trained dermatologists and plastic surgeons continue to support rapid device uptake across the United States and Canada.

Countries and Regions Covered

Asia-Pacific (Dominating Region)

o South Korea (Largest Country Market)

o China (Fastest-Growing Country Market)

o Japan

o India

o Rest of Asia-Pacific

North America (Fastest-Growing Region)

o United States (Largest Country Market)

o Mexico

o Canada

Europe

o Germany (Largest Country Market)

o United Kingdom

o France

o Italy

o Rest of Europe

Latin America

o Brazil (Largest Country Market)

o Chile

o Rest of Latin America

Middle East & Africa

o United Arab Emirates (Largest Country Market)

o Saudi Arabia (Fastest-Growing Country Market)

o Rest of Middle East & Africa

Market Share

The market is consolidated, with established manufacturers including Merz Aesthetics, Classys, Jeisys Medical, Sofwave Medical, Hironic, WONTECH, KORUST, Eunsung Global, Sincoheren, Newangie, BTL Industries, Zemits, Chungwoo Medical, AMT Engineering, and ITC accounting for a substantial share of global installed platforms, alongside a long tail of regional Korean and Chinese manufacturers competing primarily on price, portability, and treatment versatility. Key success factors include depth of published clinical evidence, breadth of regulatory clearances across major markets, direct clinic relationships that support recurring consumable revenue, and speed of new-indication approvals. Leading companies are prioritizing direct commercial operations in the United States, Europe, and Latin America in place of third-party distributors, vertical expansion into consumables and applicators, and international regulatory filings to unlock entry into China and other high-growth Asian markets. Private-equity-backed consolidation, including ARCHIMED’s acquisition of Jeisys Medical, is supporting continued investment in global expansion, clinical evidence generation, and product development as scaled platforms seek to strengthen their competitive positions against smaller independent manufacturers.

Key Players

· Merz Aesthetics GmbH (Germany)

· Classys Inc. (South Korea)

· Jeisys Medical Inc. (South Korea)

· Sofwave Medical Ltd. (Israel)

· Hironic Co., Ltd. (South Korea)

· WONTECH Co., Ltd. (South Korea)

· KORUST Co., Ltd. (South Korea)

· Eunsung Global Corporation (South Korea)

· Sincoheren Co., Ltd. (China)

· Guangzhou Newangie Medical Beauty Equipment Co., Ltd. (China)

· BTL Industries Ltd. (Czech Republic)

· Zemits (US)

· Chungwoo Medical Co., Ltd. (South Korea)

· AMT Engineering Co., Ltd. (South Korea)

· ITC Co., Ltd. (South Korea)

Recent Market Developments

April 2025: WONTECH received Vietnam Ministry of Health certification for UltraSkin Tightan II, a non-invasive HIFU device, supporting the company's expansion of its ultrasound aesthetic portfolio in Southeast Asia.
April 2025: Jeisys Medical showcased its LinearZ HIFU platform at the 2025 KOAT Spring Conference in South Korea, highlighting the device alongside its other flagship aesthetic technologies and strengthening physician engagement.
November 2025: KORUST presented its RHINOS HIFU system at MEDICA 2025, following CE certification and positioning the focused-ultrasound platform for international expansion and distributor partnerships.
August 2026: Sofwave Medical surpassed one million Sofwave treatments worldwide, with the milestone treatment performed in South Korea; the company reported more than 975,000 treatments by June 2026.

Frequently Asked Questions

What is the Ultrasound Aesthetic Devices Market?

It covers medical devices that deliver focused or fractionated ultrasound energy, primarily high-intensity focused ultrasound (HIFU) and micro-focused ultrasound with visualization (MFU-V), for non-invasive skin lifting, tightening, resurfacing and body contouring.